ASHLEY SPRINKLE: Open Payments
NPI 1629855580 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,407 in 83 payments from 15 companies in 2025. Trend: 2023 $289 · 2024 $991 · 2025 $1,407
Food & beverage: $1,407
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 21 | $428 |
| ABBVIE INC. | 25 | $236 |
| Otsuka America Pharmaceutical, Inc. | 9 | $223 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $218 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Exact Sciences Corporation | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
Products named: FANAPT, REXULTI, CAPLYTA, VRAYLAR, UBRELVY, QULIPTA, BREZTRI, COBENFY.
Industry payments across MI — which companies pay providers there.
